[Information in English is below] Merchant Law Group LLP intente un recours collectif contre Merck Frosst Canada concernant Propecia et Proscar (finasteride et dutasteride). Le recours collectif demandera une compensation financière pour les Canadiens touchés. Veuillez noter que joindre notre liste de contacts pour ce recours collectif ne crée aucune obligation financière pour vous, et vos informations resteront confidentielles. REMPLIR LE FORMULAIRE CI-DESSOUS OU CONTACTER NOTRE BUREAU DE MONTRÉAL: [email protected] Merchant Law Group LLP is pursuing class action litigation against Merck Frosst Canada on behalf of Canadians who used Propecia or Proscar (generically known as finasteride) and suffered medical information. POUR UN SERVICE EN FRANÇAIS AU SUJET DE CE RECOURS COLLECTIF (OU D’AUTRES RECOURS POTENTIELS), S. These medications, which are normally used to treat baldness and enlarged prostates, are alleged to cause various injuries, including an increased risk of a serious form of prostate cancer known as high-grade prostate cancer, male breast cancer, sexual dysfunction, and other health difficulties. Propecia and Proscar are normally prescribed as a cosmetic treatment for male pattern hair loss also known as androgenic alopecia. It is alleged that the drug manufacturers failed to adequately warn Canadians of the risks associated with the drugs and that the warning remains inadequate. The monograph product information has already been changed in several European countries to include an adverse reaction warning of persistent erectile dysfunction after discontinuation. is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M. A.) IF YOU WISH TO JOIN OUR CONTACT LIST FOR THIS CLASS ACTION, PLEASE COMPLETE THE BELOW FORM. If you wish to be kept advised as to the progress of this case, please complete the contact form below. are well known for pursuing class action lawsuits in Canada including litigation regarding Winners/Home Sense, Various Cellular Phone Fees, BCE Dividends, GM Gasket Manifolds, Hip Implants, Lead Paint in Toys (and similar consumer products), Maple Leaf, Celebrex/Bextra, Vioxx, Sony, Residential Schools and various other cases. (Please note, providing your contact information creates no financial obligation for you. These side effects may persist even after no longer using the medication. were previously reviewing potential lawsuits for men throughout the United States who have experienced erectile dysfunction, impotence and other sexual problems from Propecia or Proscar. Financial compensation may be available through a Propecia lawsuit as a result of the manufacturer’s failure to adequately warn about the risk of permanent injury that may be suffered after taking the prescription medication to prevent or reverse male hair loss. New cases are no longer being accepted by Saiontz & Kirk, P. This page is maintained for informational purposes only. Propecia (finasteride) is a prescription medication introduced by Merck in December 1997 for treatment of male pattern baldness or hair loss. It is a low-dose version of the prostate drug Proscar, which also contains finasteride as the active pharmaceutical ingredient. Side effects of Propecia have been linked to a risk of irreversible sexual problems that may persist even after the popular hair loss medication is stopped, such as: Although it appears that Merck knew or should have known about this risk of Propecia problems, they failed to adequately warn consumers or the medical community, placing their desire for profits before the safety of men using the medication.
This class action is against Merck Frosst Canada on behalf of Canadian men who used Propecia and/or Proscar, a drug used to treat male pattern hair loss. Drug class 5α-Reductase inhibitor ATC. which was marketed under the brand name Propecia. The first study of finasteride in the treatment of hirsutism in women.